EU guidelines clear way for biosimilar antibodies | Reuters
European regulators on Friday set out broad guidelines for the approval of biosimilar antibody drugs, including lower hurdles than for new medicines and allowing the possibility of different diseases being addressed by the same copy antibody.
No comments:
Post a Comment